Role of interferons in demyelinating diseases

Journal of Neural Transmission, Supplement

Volumn , Issue 49, 1997, Pages 117-123

  Arnason, B G W ^a   Toscas, A ^a   Dayal, A ^a   Qu, Z ^a   Noronha, A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; PLACEBO; BETA INTERFERON; BETA1A INTERFERON; GAMMA INTERFERON; INTERFERON BETA-1B; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATING DISEASE; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; BIOSYNTHESIS; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY;

DEMYELINATING DISEASES; HUMANS; INTERFERON TYPE II; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030612203     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6844-8_13     Document Type: Review

References (23)

1. Antel JP, Arnason BGW, Medof ME (1979) Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol 5: 338-342
2. Arnason BGW (1993) Interferon beta in multiple sclerosis. Neurology 43: 641-643
3. Arnason BGW, Antel JP (1978) Suppressor cell function in multiple sclerosis. Ann Immunol (Paris) 129C: 159-170
4. Arnason BGW, Reder AT (1994) Interferons and multiple sclerosis. Clin Neuropharmacol 17: 495-547
5. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Scand 78: 318-323
6. ser in healthy volunteers and its effect on serum neopterin. Pharm Res 10: 567-572
7. Dayal AS, Jensen MA, Lledo A, Arnason BGW (1995) Interferon gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1B. Neurology 45: 2173-2177
8. IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis I. Clinical results of a multicenter, randomized, doubleblind, placebo-controlled trial. Neurology 43: 655-661
9. Jacobs L, Cookfair D, Rudick R, et al (1994) Results of a phase III trial of intramuscular recombinant beta interferon as treatment for multiple sclerosis. Ann Neurol 36: 259
10. -/- mice. Science 256: 1210-1213
11. Lu C-Z, Jensen MA, Arnason BGW (1993) Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol 46: 123-128
12. Noronha A, Toscas A, Jensen MA (1990) Interferon beta augments suppressor cell function in multiple sclerosis. Ann Neurol 27: 207-210
13. Noronha A, Toscas A, Jensen MA (1992) Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor cell functions in multiple sclerosis. Ann Neurol 31: 103-106
14. Noronha A, Toscas A, Jensen MA (1993a) Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J Neuroimmunol 46: 145-154
15. Noronha A, Jensen M, Toscas A (1993b) TGF-b activity in MS: effect of IFN-b. Neurology 43 [Suppl]: 355
16. Noronha A, Toscas A, Arnason BGW, Jensen M (1994) IFN-beta augments in vivo suppressor function in MS. Neurology 44 [Suppl]: A212
17. Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987a) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37: 1097-1102
18. Panitch HS, Folus JS, Johnson KP (1987b) Recombinant beta interferon inhibits gamma interferon production in multiple sclerosis. Ann Neurol 22: 139
19. Panitch HS, Bever CT, Katz E, Johnson KP (1991a) Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferon-β [abstract]. J Neuroimmunol 35 [Suppl 1]: 125
20. Panitch HS, Folus JS, Johnson KP (1991b) Activated suppressor cells inhibit synthesis of interferon-g in patients with multiple sclerosis and normal subjects [abstract]. J Neuroimmunol 35 [Suppl 1]: 186
21. Paty DW, Li DKB (1993) UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis II. MRI analysis results of a multicenter, double-blind, placebo-controlled trial. Neurology 43: 655-661
22. Spear GT, Paulnock DM, Jordan RL, Meltzer DM, Merritt JA, Borden EC (1987) Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo β-interferon. Clin Exp Immunol 69: 107-115
23. Sibley WA, Bamford CR, Clark KI (1985) Clinical viral infections and multiple sclerosis. Lancet 1: 1313-1315